318 related articles for article (PubMed ID: 27223344)
1. Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.
Benjamin H; Schnitzer-Perlman T; Shtabsky A; VandenBussche CJ; Ali SZ; Kolar Z; Pagni F; ; Bar D; Meiri E
Cancer Cytopathol; 2016 Oct; 124(10):711-721. PubMed ID: 27223344
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
Nikiforova MN; Lepe M; Tolino LA; Miller ME; Ohori NP; Wald AI; Landau MS; Kaya C; Malapelle U; Bellevicine C; Troncone G; Nikiforov YE; Baloch Z
Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
[TBL] [Abstract][Full Text] [Related]
3. Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.
Lithwick-Yanai G; Dromi N; Shtabsky A; Morgenstern S; Strenov Y; Feinmesser M; Kravtsov V; Leon ME; Hajdúch M; Ali SZ; VandenBussche CJ; Zhang X; Leider-Trejo L; Zubkov A; Vorobyov S; Kushnir M; Goren Y; Tabak S; Kadosh E; Benjamin H; Schnitzer-Perlman T; Marmor H; Motin M; Lebanony D; Kredo-Russo S; Mitchell H; Noller M; Smith A; Dattner O; Ashkenazi K; Sanden M; Berlin KA; Bar D; Meiri E
J Clin Pathol; 2017 Jun; 70(6):500-507. PubMed ID: 27798083
[TBL] [Abstract][Full Text] [Related]
4. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
5. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules.
Walsh PS; Wilde JI; Tom EY; Reynolds JD; Chen DC; Chudova DI; Pagan M; Pankratz DG; Wong M; Veitch J; Friedman L; Monroe R; Steward DL; Lupo MA; Lanman RB; Kennedy GC
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2297-306. PubMed ID: 23087323
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
[TBL] [Abstract][Full Text] [Related]
7. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
8. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
[TBL] [Abstract][Full Text] [Related]
11. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
[TBL] [Abstract][Full Text] [Related]
12. Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides.
Santos MTD; Buzolin AL; Gama RR; Silva ECAD; Dufloth RM; Figueiredo DLA; Carvalho AL
Thyroid; 2018 Dec; 28(12):1618-1626. PubMed ID: 30319072
[No Abstract] [Full Text] [Related]
13. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
14. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
15. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
16. Three-gene molecular diagnostic model for thyroid cancer.
Prasad NB; Kowalski J; Tsai HL; Talbot K; Somervell H; Kouniavsky G; Wang Y; Dackiw AP; Westra WH; Clark DP; Libutti SK; Umbricht CB; Zeiger MA
Thyroid; 2012 Mar; 22(3):275-84. PubMed ID: 22280184
[TBL] [Abstract][Full Text] [Related]
17. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
18. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
[TBL] [Abstract][Full Text] [Related]
19. The utility of molecular markers in pre-operative assessment of thyroid nodules.
Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.
Sciacchitano S; Lavra L; Ulivieri A; Magi F; De Francesco GP; Bellotti C; Salehi LB; Trovato M; Drago C; Bartolazzi A
Oncotarget; 2017 Jul; 8(30):49421-49442. PubMed ID: 28472764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
